Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Higher iron levels in the blood are not linked to increased hair loss in women.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Spironolactone plus finasteride reduces hirsutism more effectively.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Androgens may block hair growth signals, targeting this could treat hair loss.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.